Your browser is no longer supported. Please, upgrade your browser.
Settings
NEO NeoGenomics, Inc. daily Stock Chart
NEO [NASD]
NeoGenomics, Inc.
Index- P/E- EPS (ttm)-0.07 Insider Own3.80% Shs Outstand87.33M Perf Week-7.46%
Market Cap1.09B Forward P/E60.53 EPS next Y0.21 Insider Trans-23.62% Shs Float73.11M Perf Month-10.24%
Income-4.80M PEG- EPS next Q0.02 Inst Own86.60% Short Float8.92% Perf Quarter11.38%
Sales262.00M P/S4.18 EPS this Y53.80% Inst Trans4.60% Short Ratio10.93 Perf Half Y71.41%
Book/sh2.03 P/B6.17 EPS next Y37.09% ROA-0.50% Target Price16.00 Perf Year34.88%
Cash/sh0.11 P/C116.41 EPS next 5Y20.00% ROE-1.00% 52W Range7.08 - 15.00 Perf YTD41.42%
Dividend- P/FCF40.23 EPS past 5Y28.18% ROI0.70% 52W High-16.47% Beta0.61
Dividend %- Quick Ratio1.60 Sales past 5Y34.00% Gross Margin45.70% 52W Low76.98% ATR0.54
Employees1000 Current Ratio1.70 Sales Q/Q8.70% Oper. Margin1.70% RSI (14)35.36 Volatility4.01% 4.01%
OptionableYes Debt/Eq0.84 EPS Q/Q342.00% Profit Margin-0.70% Rel Volume0.65 Prev Close12.65
ShortableYes LT Debt/Eq0.77 EarningsJul 24 BMO Payout- Avg Volume596.30K Price12.53
Recom1.60 SMA20-8.77% SMA50-7.65% SMA20024.07% Volume387,314 Change-0.95%
May-02-18Downgrade First Analysis Sec Overweight → Equal-Weight $11
Sep-11-17Downgrade BTIG Research Buy → Neutral
Aug-24-17Initiated Gabelli & Co Buy $9
Dec-15-16Initiated Cantor Fitzgerald Overweight $11
Oct-04-16Initiated First Analysis Sec Overweight $11
Jul-27-16Reiterated The Benchmark Company Buy $10 → $12
Apr-28-16Reiterated The Benchmark Company Buy $8 → $9
Mar-11-16Initiated The Benchmark Company Buy $8
Oct-26-15Resumed ROTH Capital Buy $7.50 → $10
Jul-13-15Reiterated ROTH Capital Buy $7 → $7.50
May-14-14Initiated Dawson James Buy $6
Apr-25-13Downgrade Ladenburg Thalmann Buy → Neutral
Feb-14-13Reiterated Ladenburg Thalmann Buy $3.50 → $3.75
Aug-09-18 08:40PM  NeoGenomics Announces Pricing on Public Offering of Common Stock GlobeNewswire
Aug-06-18 04:19PM  NeoGenomics Announces Proposed Public Offering of Common Stock GlobeNewswire
Jul-30-18 09:30AM  EBS vs. NEO: Which Stock Should Value Investors Buy Now? Zacks
Jul-27-18 07:45AM  Breakfast Technical Briefing on TrovaGene and Three Other Additional Medical Research Stocks ACCESSWIRE
Jul-24-18 07:03PM  Edited Transcript of NEO earnings conference call or presentation 24-Jul-18 12:30pm GMT Thomson Reuters StreetEvents
07:18AM  NeoGenomics: 2Q Earnings Snapshot Associated Press
07:00AM  NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog GlobeNewswire
06:30AM  NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
Jul-23-18 04:18PM  Earnings Preview For NeoGenomics Benzinga
Jul-11-18 09:30AM  EBS vs. NEO: Which Stock Is the Better Value Option? Zacks
Jul-02-18 04:05PM  NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018 GlobeNewswire +5.03%
Jun-29-18 07:30AM  [$$] GE Is Doing Well---in Its Stock Investments Barrons.com
Jun-26-18 02:25PM  Is NeoGenomics Incs (NASDAQ:NEO) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Jun-25-18 04:05PM  NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock GlobeNewswire
Jun-21-18 08:00AM  Report: Developing Opportunities within ABIOMED, Avid Technology, Unit, Omeros, Strayer Education, and NeoGenomics Future Expectations, Projections Moving into 2018 GlobeNewswire
Jun-01-18 08:00AM  PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions GlobeNewswire +8.10%
May-25-18 04:05PM  NeoGenomics to Participate In Two Upcoming Investor Conferences GlobeNewswire
May-02-18 05:35PM  Edited Transcript of NEO earnings conference call or presentation 1-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-01-18 09:45AM  NeoGenomics: 1Q Earnings Snapshot Associated Press
07:45AM  Detailed Research: Economic Perspectives on NeoGenomics, Illinois Tool Works, Carriage Services, Gorman-Rupp, Fiesta Restaurant Group, and American Financial Group What Drives Growth in Today's Competitive Landscape GlobeNewswire
07:00AM  NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018 Marketwired
06:45AM  NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
Apr-02-18 05:00PM  NeoGenomics Schedules its First Quarter Earnings Release for May 1, 2018 Marketwired
Mar-20-18 07:00AM  NeoGenomics Announces Executive Appointments Marketwired
Mar-19-18 08:25AM  Research Report Identifies Chatham Lodging Trust (REIT), Independent Bank Group, NeoGenomics, Black Knight, Aethlon Medical, and PRA Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-07-18 07:13AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating NeoGenomics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Feb-21-18 08:31PM  Edited Transcript of NEO earnings conference call or presentation 21-Feb-18 3:00pm GMT Thomson Reuters StreetEvents +9.78%
07:55AM  NeoGenomics beats Street 4Q forecasts Associated Press
07:20AM  NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
07:00AM  NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017 Marketwired
Jan-30-18 07:00AM  NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2017 Earnings Release for February 21, 2018 Marketwired
Jan-09-18 07:30AM  Detailed Research: Economic Perspectives on Fluidigm, Stemline Therapeutics, NeoGenomics, CVR Energy, W.R. Berkley, and Mack-Cali Realty What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jan-01-18 07:42AM  NeoGenomics, Inc. breached its 50 day moving average in a Bearish Manner : NEO-US : January 1, 2018 Capital Cube
Dec-19-17 01:42PM  ETFs with exposure to NeoGenomics, Inc. : December 19, 2017 Capital Cube
Dec-18-17 11:13AM  NeoGenomics, Inc. :NEO-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017 Capital Cube
Dec-15-17 02:47PM  NeoGenomics, Inc. Value Analysis (NASDAQ:NEO) : December 15, 2017 Capital Cube
Dec-14-17 08:05AM  NeoGenomics, Inc. breached its 50 day moving average in a Bearish Manner : NEO-US : December 14, 2017 Capital Cube
Dec-06-17 07:00AM  NeoGenomics Announces Six Clinical Data Presentations to be Made at the American Society of Hematology Meeting Marketwired
Dec-05-17 07:00AM  NeoGenomics Joins Thermo Fisher Scientific's Companion Diagnostic Center of Excellence Program with the Launch of Oncomine Dx Target Test Marketwired
Nov-15-17 08:05AM  See what the IHS Markit Score report has to say about Neogenomics Inc. Markit
Nov-14-17 08:05AM  Zacks.com highlights: Apache, PTC, NeoGenomics, Titan International and AMC Entertainment Holdings Zacks
Nov-09-17 07:00AM  NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials Marketwired
Oct-25-17 04:26PM  Edited Transcript of NEO earnings conference call or presentation 25-Oct-17 2:00pm GMT Thomson Reuters StreetEvents
07:21AM  NeoGenomics reports 3Q loss Associated Press
07:05AM  NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
07:00AM  NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017 Marketwired
Oct-24-17 04:10PM  Investor Network Invites You to the NeoGenomics Third Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, October 25, 2017 ACCESSWIRE -5.97%
09:40AM  ETFs with exposure to NeoGenomics, Inc. : October 24, 2017 Capital Cube
09:00AM  NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials Marketwired
Oct-16-17 10:11AM  Company News For Oct 16, 2017 Zacks
08:31AM  NeoGenomics, Inc. breached its 50 day moving average in a Bearish Manner : NEO-US : October 16, 2017 Capital Cube
Oct-13-17 11:05AM  ETFs with exposure to NeoGenomics, Inc. : October 13, 2017 Capital Cube -15.07%
Oct-12-17 04:01PM  NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance Marketwired
Oct-02-17 10:58AM  ETFs with exposure to NeoGenomics, Inc. : October 2, 2017 Capital Cube
Sep-29-17 08:55AM  NeoGenomics, Inc. :NEO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-28-17 07:00AM  NeoGenomics Schedules its Q3 2017 Earnings Release for October 25, 2017 Marketwired
Sep-11-17 03:04PM  NeoGenomics Reports on Impacts from Hurricane Irma Marketwired
Aug-13-17 03:26AM  Edited Transcript of NEO earnings conference call or presentation 25-Jul-17 2:00pm GMT Thomson Reuters StreetEvents
Jul-25-17 04:56PM  NeoGenomics reports 2Q loss Associated Press
07:15AM  Investor Network: NeoGenomics, Inc. to Host Earnings Call Accesswire
07:00AM  NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017 Marketwired
Jul-24-17 04:05PM  Investor Network Invites You to the NeoGenomics Second Quarter 2017 Earnings Conference Call and Webcast Live on Tuesday, July 25, 2017 Accesswire
09:30AM  Zacks.com featured highlights: Live Nation Entertainment, NeoGenomics, Salesforce.com, Paycom Software and Covanta Holding Zacks
Jul-03-17 03:29PM  ETFs with exposure to NeoGenomics, Inc. : July 3, 2017 Capital Cube
Jun-28-17 07:00AM  NeoGenomics Schedules its Q2 2017 Earnings Release for July 25, 2017 Marketwired
Jun-22-17 04:04PM  ETFs with exposure to NeoGenomics, Inc. : June 22, 2017 Capital Cube
Jun-20-17 09:30AM  Zacks.com featured highlights: Etsy, Live Nation Entertainment, Salesforce.com, Vertex Pharmaceuticals and NeoGenomics Zacks
Jun-08-17 01:48PM  ETFs with exposure to NeoGenomics, Inc. : June 8, 2017 Capital Cube
Jun-06-17 09:18AM  NeoGenomics, Inc. :NEO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017 Capital Cube
Jun-05-17 08:38AM  NeoGenomics, Inc. breached its 50 day moving average in a Bullish Manner : NEO-US : June 5, 2017 Capital Cube
Jun-02-17 07:00AM  NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests Marketwired
May-15-17 08:52AM  NeoGenomics Reports that its NeoLAB(R) Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer Marketwired
Apr-27-17 09:36PM  Edited Transcript of NEO earnings conference call or presentation 26-Apr-17 3:00pm GMT Thomson Reuters StreetEvents
Apr-26-17 12:28PM  Here's Why NeoGenomics, Inc. Is Dropping Today Motley Fool -9.05%
07:54AM  NeoGenomics reports 1Q loss Associated Press
Apr-25-17 04:05PM  Investor Network Invites You to the NeoGenomics First Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, April 26, 2017 Accesswire
03:42PM  ETFs with exposure to NeoGenomics, Inc. : April 25, 2017 Capital Cube
Apr-20-17 07:00AM  NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development Marketwired
Apr-19-17 03:10PM  NeoGenomics, Inc. Value Analysis (NASDAQ:NEO) : April 19, 2017 Capital Cube
Apr-18-17 08:29AM  NeoGenomics, Inc. breached its 50 day moving average in a Bullish Manner : NEO-US : April 18, 2017 Capital Cube
Apr-14-17 04:01PM  NeoGenomics Schedules its Q1 2017 Earnings Release for April 26, 2017 Marketwired
Mar-17-17 01:04PM  NEOGENOMICS INC Financials
Mar-15-17 10:32AM  Moving Average Crossover Alert: NeoGenomics (NEO) Zacks
Mar-14-17 06:07AM  NEOGENOMICS INC Files SEC form 10-K, Annual Report
Mar-13-17 07:00AM  NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing Marketwired
07:00AM  NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing Business Wire
Feb-23-17 01:18PM  NEOGENOMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
12:48PM  NeoGenomics, Inc. :NEO-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017 Capital Cube
12:48PM  NeoGenomics, Inc. :NEO-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017
10:38AM  NeoGenomics, Inc. :NEO-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017
Feb-22-17 04:28PM  Edited Transcript of NEO earnings conference call or presentation 22-Feb-17 4:00pm GMT Thomson Reuters StreetEvents
10:43AM  NEOGENOMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:23AM  NeoGenomics reports 4Q loss Associated Press
07:00AM  NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016 Marketwired
Feb-21-17 04:05PM  Investor Network Invites You to the NeoGenomics Fourth Quarter and Full Year 2016 Earnings Conference Call and Webcast Live on Wednesday, February 22, 2017 Accesswire
Feb-15-17 07:09AM  NEOGENOMICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Feb-08-17 11:22AM  NeoGenomics Schedules its Q4 and Full Year 2016 Earnings Release for February 22, 2017 Marketwired
Jan-06-17 10:45AM  NeoGenomics, Inc. Value Analysis (NASDAQ:NEO) : January 6, 2017 Capital Cube
10:45AM  NeoGenomics, Inc. Value Analysis (NASDAQ:NEO) : January 6, 2017
Jan-05-17 08:02AM  NeoGenomics, Inc. breached its 50 day moving average in a Bullish Manner : NEO-US : January 5, 2017
NeoGenomics, Inc., together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories in the United States. It operates through Clinical Services and Pharma Services segments. The company laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, and other clinical laboratories. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients' oncology programs, as well as acts as a reference laboratory supplying anatomic pathology testing services. The company has a strategic alliance with Pharmaceutical Product Development Inc. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JONES STEVEN CExecutive Vice PresidentAug 01Sale14.00119,9481,679,2722,300,000Aug 01 07:56 PM
JONES STEVEN CExecutive Vice PresidentJul 31Sale14.0038,952545,3282,419,948Aug 01 07:56 PM
JONES STEVEN CExecutive Vice PresidentJul 30Sale14.0144,600624,81148,657Aug 01 07:56 PM
SHOVLIN ROBERT J.President, Clinical ServicesJun 29Sale13.1212,941169,78639,884Jun 29 05:21 PM
JONES STEVEN CExecutive Vice PresidentJun 22Sale14.0489,6881,259,2202,500,000Jun 26 05:29 PM
JONES STEVEN CExecutive Vice PresidentJun 19Sale13.32158,3122,108,0672,589,688Jun 19 06:54 PM
JONES STEVEN CExecutive Vice PresidentJun 15Sale13.252,00026,5002,748,000Jun 19 06:54 PM
JONES STEVEN CExecutive Vice PresidentJun 01Sale12.12230,5332,794,0602,750,000Jun 05 05:42 PM
JONES STEVEN CExecutive Vice PresidentMay 31Sale11.6817,548204,9612,980,533May 31 05:54 PM
JONES STEVEN CExecutive Vice PresidentMay 30Sale11.7237,619440,8952,998,081May 31 05:54 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 29Option Exercise4.7865,000310,70078,322May 31 05:50 PM
JONES STEVEN CExecutive Vice PresidentMay 29Sale11.67114,3001,333,8813,035,700May 31 05:54 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 29Sale11.6665,000758,10013,322May 31 05:50 PM
VAN OORT DOUGLAS MChairman and CEOMay 25Option Exercise0.0065,68001,898,665May 29 07:00 PM
CARDOZA GEORGEPresident, Pharma ServicesMay 25Option Exercise0.008,3330197,422May 29 06:57 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 25Option Exercise0.006,66606,666May 29 06:51 PM
SHOVLIN ROBERT J.President, Clinical ServicesMay 25Option Exercise0.0016,666023,216May 29 06:36 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 15Option Exercise4.7813,00062,14013,000May 17 03:35 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 15Sale11.2413,000146,0550May 17 03:35 PM
ROSS STEVEN ACIOMay 10Option Exercise6.2781,999514,51886,499May 10 05:53 PM
ROSS STEVEN ACIOMay 10Sale10.7881,999883,9494,500May 10 05:53 PM
BALLIET JENNIFERVP and Chief Culture OfficerMar 28Option Exercise4.787,00033,4607,000Mar 28 04:57 PM
BALLIET JENNIFERVP and Chief Culture OfficerAug 24Option Exercise3.5522,50079,95022,500Aug 25 02:44 PM